市場調査レポート
商品コード
1107769

臨床検査サービスの世界市場:検査室タイプ別、専門分野別、用途別、地域別分析-予測(~2028年)

Clinical Laboratory Services Market Forecasts to 2028 - Global Analysis By Laboratory Type (Hospital, Commercial), Specialty (Hematology, Clinical Chemistry), Application, and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
臨床検査サービスの世界市場:検査室タイプ別、専門分野別、用途別、地域別分析-予測(~2028年)
出版日: 2022年07月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床検査サービスの市場規模は、2022年に2,195億7,000万米ドルとなり、予測期間中に6.7%のCAGRで成長し、2028年には3,240億1,000万米ドルに達すると予測されています。

当レポートでは、世界の臨床検査サービス市場について調査分析し、市場の促進要因、抑制要因、COVID-19の影響、検査室タイプ・サービスプロバイダー・専門分野・製品・所有権・用途・地域別市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • 用途分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の臨床検査サービス市場:検査室タイプ別

  • 病院
  • 商業

第6章 世界の臨床検査サービス市場:サービスプロバイダー別

  • スタンドアロン検査室
  • 看護師・医師のオフィスベース検査室
  • 独立/私立およびリファレンス検査室
  • 病院ベース検査室
  • 受託調査機関(CRO)
  • クリニックベース検査室

第7章 世界の臨床検査サービス市場:専門分野別

  • 医療用微生物検査
    • アンドロロジー
    • 血液バンク・輸血医療
    • ヒト白血球抗原(HLA)タイピング
    • 感染症検査
    • 移植診断検査
  • 血液検査
    • 凝固検査
    • 定期的な血液検査
    • 特殊な血液検査
  • ヒトおよび腫瘍遺伝子検査
  • 免疫検査・免疫化学
  • 細胞学および組織学検査
  • 臨床化学検査
    • 内分泌化学検査
    • ルーチン化学検査
    • 特殊化学検査
    • 治療薬モニタリング(TDM)検査
  • 生化学
  • エソテリック検査
  • 食物不耐症検査
  • 病理組織学および解剖病理学サービス
  • 尿検査
  • その他の専門分野
    • 毛髪検査
    • 口腔液検査

第8章 世界の臨床検査サービス市場:製品別

  • 機器
  • 試薬
  • サービス

第9章 世界の臨床検査サービス市場:所有権別

  • 民間
  • 公共

第10章 世界の臨床検査サービス市場:用途別

  • 毒性検査サービス(乱用薬物検査)
  • 前臨床および臨床検査関連サービス
  • 創薬・開発関連サービス
  • 細胞・遺伝子治療関連サービス
  • 生物分析および実験化学サービス

第11章 世界の臨床検査サービス市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第12章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡大
  • その他の主要戦略

第13章 企業プロファイル

  • Sonic Healthcare
  • Viapath
  • Spectra Laboratories
  • ACM Global Laboratories
  • BioReference Laboratories
  • Quest Diagnostics
  • Clinical Reference Laboratory
  • OPKO Health, Inc.
  • NeoGenomics Laboratories
  • Eurofins Scientific
  • Labcorp
  • Fresenius Medical Care
  • Myriad Genetics
  • Charles River Laboratories
  • QIAGEN
  • Mindray
  • Bio-Rad Laboratories
  • Deep Bio
  • Siemens Healthineers
  • Abbott Laboratories
図表

List of Tables

  • Table 1 Global Clinical Laboratory Services Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Clinical Laboratory Services Market Outlook, By Laboratory Type (2020-2028) ($MN)
  • Table 3 Global Clinical Laboratory Services Market Outlook, By Hospital (2020-2028) ($MN)
  • Table 4 Global Clinical Laboratory Services Market Outlook, By Commercial (2020-2028) ($MN)
  • Table 5 Global Clinical Laboratory Services Market Outlook, By Service Provider (2020-2028) ($MN)
  • Table 6 Global Clinical Laboratory Services Market Outlook, By Stand-Alone Laboratories (2020-2028) ($MN)
  • Table 7 Global Clinical Laboratory Services Market Outlook, By Nursing and Physician Office-Based Laboratories (2020-2028) ($MN)
  • Table 8 Global Clinical Laboratory Services Market Outlook, By Independent/Private and Reference Laboratories (2020-2028) ($MN)
  • Table 9 Global Clinical Laboratory Services Market Outlook, By Hospital-Based Laboratories (2020-2028) ($MN)
  • Table 10 Global Clinical Laboratory Services Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 11 Global Clinical Laboratory Services Market Outlook, By Clinic-Based Laboratories (2020-2028) ($MN)
  • Table 12 Global Clinical Laboratory Services Market Outlook, By Specialty (2020-2028) ($MN)
  • Table 13 Global Clinical Laboratory Services Market Outlook, By Medical Microbiology Testing (2020-2028) ($MN)
  • Table 14 Global Clinical Laboratory Services Market Outlook, By Andrology (2020-2028) ($MN)
  • Table 15 Global Clinical Laboratory Services Market Outlook, By Blood Bank/ Transfusion Medicine (2020-2028) ($MN)
  • Table 16 Global Clinical Laboratory Services Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2020-2028) ($MN)
  • Table 17 Global Clinical Laboratory Services Market Outlook, By Infectious Diseases Testing (2020-2028) ($MN)
  • Table 18 Global Clinical Laboratory Services Market Outlook, By Transplant Diagnostic Testing (2020-2028) ($MN)
  • Table 19 Global Clinical Laboratory Services Market Outlook, By Hematology Testing (2020-2028) ($MN)
  • Table 20 Global Clinical Laboratory Services Market Outlook, By Coagulation Testing (2020-2028) ($MN)
  • Table 21 Global Clinical Laboratory Services Market Outlook, By Routine Hematology Testing (2020-2028) ($MN)
  • Table 22 Global Clinical Laboratory Services Market Outlook, By Specialized Hematology Testing (2020-2028) ($MN)
  • Table 23 Global Clinical Laboratory Services Market Outlook, By Human and Tumor Genetic Testing (2020-2028) ($MN)
  • Table 24 Global Clinical Laboratory Services Market Outlook, By Immunology Testing/Immunochemistry (2020-2028) ($MN)
  • Table 25 Global Clinical Laboratory Services Market Outlook, By Cytology and Histology Testing (2020-2028) ($MN)
  • Table 26 Global Clinical Laboratory Services Market Outlook, By Clinical Chemistry Testing (2020-2028) ($MN)
  • Table 27 Global Clinical Laboratory Services Market Outlook, By Endocrinology Chemistry Testing (2020-2028) ($MN)
  • Table 28 Global Clinical Laboratory Services Market Outlook, By Routine Chemistry Testing (2020-2028) ($MN)
  • Table 29 Global Clinical Laboratory Services Market Outlook, By Specialized Chemistry Testing (2020-2028) ($MN)
  • Table 30 Global Clinical Laboratory Services Market Outlook, By Therapeutic Drug Monitoring (TDM) Testing (2020-2028) ($MN)
  • Table 31 Global Clinical Laboratory Services Market Outlook, By Biochemistry (2020-2028) ($MN)
  • Table 32 Global Clinical Laboratory Services Market Outlook, By Esoteric Tests (2020-2028) ($MN)
  • Table 33 Global Clinical Laboratory Services Market Outlook, By Food Intolerance Test (2020-2028) ($MN)
  • Table 34 Global Clinical Laboratory Services Market Outlook, By Histopathology & Anatomic Pathology Services (2020-2028) ($MN)
  • Table 35 Global Clinical Laboratory Services Market Outlook, By Urinalysis (2020-2028) ($MN)
  • Table 36 Global Clinical Laboratory Services Market Outlook, By Other Specialties (2020-2028) ($MN)
  • Table 37 Global Clinical Laboratory Services Market Outlook, By Hair Testing (2020-2028) ($MN)
  • Table 38 Global Clinical Laboratory Services Market Outlook, By Oral Fluid Testing (2020-2028) ($MN)
  • Table 39 Global Clinical Laboratory Services Market Outlook, By Product (2020-2028) ($MN)
  • Table 40 Global Clinical Laboratory Services Market Outlook, By Instruments (2020-2028) ($MN)
  • Table 41 Global Clinical Laboratory Services Market Outlook, By Reagents (2020-2028) ($MN)
  • Table 42 Global Clinical Laboratory Services Market Outlook, By Services (2020-2028) ($MN)
  • Table 43 Global Clinical Laboratory Services Market Outlook, By Ownership (2020-2028) ($MN)
  • Table 44 Global Clinical Laboratory Services Market Outlook, By Private (2020-2028) ($MN)
  • Table 45 Global Clinical Laboratory Services Market Outlook, By Public (2020-2028) ($MN)
  • Table 46 Global Clinical Laboratory Services Market Outlook, By Application (2020-2028) ($MN)
  • Table 47 Global Clinical Laboratory Services Market Outlook, By Toxicology Testing Services (Drug of Abuse Testing) (2020-2028) ($MN)
  • Table 48 Global Clinical Laboratory Services Market Outlook, By Preclinical & Clinical Trial Related Services (2020-2028) ($MN)
  • Table 49 Global Clinical Laboratory Services Market Outlook, By Drug Discovery & Development Related Services (2020-2028) ($MN)
  • Table 50 Global Clinical Laboratory Services Market Outlook, By Cell & Gene Therapy Related Services (2020-2028) ($MN)
  • Table 51 Global Clinical Laboratory Services Market Outlook, By Bioanalytical & Lab Chemistry Services (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC21654

According to Stratistics MRC, the Global Clinical Laboratory Services Market is accounted for $219.57 billion in 2022 and is expected to reach $324.01 billion by 2028 growing at a CAGR of 6.7% during the forecast period. Clinical laboratory service is to detect and monitor the test results done on specimens from the body like urine or blood of the patient and provide them with appropriate treatment. A clinical laboratory has a crucial role in the healthcare system as it provides a wide range of services, including the diagnosis, treatment, prevention, and management of patients.

The increasing occurrence of targeted diseases, cardiovascular diseases, such as diabetes, high blood pressure, and lipid disorders are caused due to sedentary lifestyle and unhealthy food consumption. As per the World Health Organization (WHO), in 2018, about 1.5 million people died of tuberculosis, and it is one of the top ten causes of death across the globe. The number of people suffering from diabetes has increased from 108 million in 1980 to 422 million in 2014.

Market Dynamics:

Driver:

Rising awareness among people regarding early diagnosis

Early diagnosis of diseases such as cancer, infection, or others can essentially increase the possibilities of effective treatment at the beginning phase. So, it is one of the important public health strategies. Various governments and global associations started various initiatives to generate awareness regarding early diagnosis. Additionally, different emerging ailments have the potential to cause substantial morbidity, mortality, and economic damage. Efforts undertaken by the governments in the prevention of emerging ailments are expected to fuel the market size during the forecast timeline.

Restraint:

Lack of diagnostic tests

Pricing pressure faced by medical services payers and suppliers and procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures is likely to restrain the growth of the market during the forecast period. It would also have a considerable impact on the profit margins due to the additional costs and possible delays in introducing newly developed tests.

Opportunity:

Rising adoption of automated technologies

The rising adoption of automated technologies to improve efficiency and reduce cost is likely to augment the growth of the market. The introduction of accurate and technologically advanced products, such as companion diagnostics, biochips, and microarrays, has bolstered the demand for early disease detection. The key players in the industry are introducing new services in the market to serve the patients, which in turn provide ample opportunities for market growth.

Threat:

Lack of skilled professionals

Testing and diagnostics are troublesome and require trained professionals. In 2020, owing to the COVID-19 pandemic, many healthcare professionals and lab professionals were affected. This generated a huge shortage of lab professionals and it was quite difficult to generate accurate data. Thus, skilled professionals are required by clinical laboratories to flourish in the coming years.

The stand-alone laboratories segment is expected to be the largest during the forecast period

The stand-alone laboratories segment is estimated to have a lucrative growth owing to the increasing pervasiveness of rare genetic disorders positively influencing technologically advanced stand-alone laboratories. Stand-alone laboratories are proficient to perform different genetic disease testing because of accessibility to advanced diagnostics devices for accurate and efficient detection.

The human and tumor genetic testing segment is expected to have the highest CAGR during the forecast period

The human and tumor genetic testing segment is anticipated to witness the fastest CAGR growth during the forecast period owing to the high prevalence of cancer and tumor cases in the population poised to upsurge the industry progression for clinical laboratory tests. Likewise, the availability of analytical instruments quantifies various types of cancer which enables diagnostic decisions and better surgical performance, thereby augmenting the segment growth.

Region with highest share:

North America is projected to hold the largest market share during the forecast period due to the increasing prevalence of chronic diseases, growing healthcare expenditure, technological advancements in clinical testing techniques, favorable regulatory policies, and supportive reimbursement policies. Furthermore, the presence of a large number of laboratories and ease of diagnosis in this region are also driving the market growth

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period due to the rising healthcare expenditure, increasing number of hospitals and clinical diagnostic laboratories in India and China, and strengthening research base for clinical laboratory testing procedures across India, China, and Japan.

Key players in the market

Some of the key players profiled in the Clinical Laboratory Services Market include Sonic Healthcare, Viapath, Spectra Laboratories, ACM Global Laboratories, BioReference Laboratories, Quest Diagnostics, Clinical Reference Laboratory, OPKO Health, Inc., NeoGenomics Laboratories, Eurofins Scientific, Labcorp, Fresenius Medical Care, Myriad Genetics, Charles River Laboratories, QIAGEN, Mindray, Bio-Rad Laboratories, Deep Bio, Siemens Healthineers, and Abbott Laboratories.

Key Developments:

In March 2022, Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.

In July 2021, Deep Bio announced a research collaboration agreement with ARUP Laboratories. This Collaboration is benefitted the company in terms of usage of artificial intelligence in diagnostics of cancer. DeepDx® Prostate, Deep Bio's AI-based prostate cancer diagnosis software, will be used for the joint research. This is the first of multiple research projects that ARUP and Deep Bio will collaborate on under the multiyear research program.

Laboratory Types Covered:

  • Hospital
  • Commercial

Service Providers Covered:

  • Stand-Alone Laboratories
  • Nursing and Physician Office-Based Laboratories
  • Independent/Private and Reference Laboratories
  • Hospital-Based Laboratories
  • Contract Research Organizations (CROs)
  • Clinic-Based Laboratories

Specialties Covered:

  • Medical Microbiology Testing
  • Hematology Testing
  • Human and Tumor Genetic Testing
  • Immunology Testing/Immunochemistry
  • Cytology and Histology Testing
  • Clinical Chemistry Testing
  • Biochemistry
  • Esoteric Tests
  • Food Intolerance Test
  • Histopathology & Anatomic Pathology Services
  • Urinalysis
  • Other Specialties

Products Covered:

  • Instruments
  • Reagents
  • Services

Ownerships Covered:

  • Private
  • Public

Applications Covered:

  • Toxicology Testing Services (Drug of Abuse Testing)
  • Preclinical & Clinical Trial Related Services
  • Drug Discovery & Development Related Services
  • Cell & Gene Therapy Related Services
  • Bioanalytical & Lab Chemistry Services

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Laboratory Services Market, By Laboratory Type

  • 5.1 Introduction
  • 5.2 Hospital
  • 5.3 Commercial

6 Global Clinical Laboratory Services Market, By Service Provider

  • 6.1 Introduction
  • 6.2 Stand-Alone Laboratories
  • 6.3 Nursing and Physician Office-Based Laboratories
  • 6.4 Independent/Private and Reference Laboratories
  • 6.5 Hospital-Based Laboratories
  • 6.6 Contract Research Organizations (CROs)
  • 6.7 Clinic-Based Laboratories

7 Global Clinical Laboratory Services Market, By Specialty

  • 7.1 Introduction
  • 7.2 Medical Microbiology Testing
    • 7.2.1 Andrology
    • 7.2.2 Blood Bank/ Transfusion Medicine
    • 7.2.3 Human Leukocyte Antigen (HLA) Typing
    • 7.2.4 Infectious Diseases Testing
    • 7.2.5 Transplant Diagnostic Testing
  • 7.3 Hematology Testing
    • 7.3.1 Coagulation Testing
    • 7.3.2 Routine Hematology Testing
    • 7.3.3 Specialized Hematology Testing
  • 7.4 Human and Tumor Genetic Testing
  • 7.5 Immunology Testing/Immunochemistry
  • 7.6 Cytology and Histology Testing
  • 7.7 Clinical Chemistry Testing
    • 7.7.1 Endocrinology Chemistry Testing
    • 7.7.2 Routine Chemistry Testing
    • 7.7.3 Specialized Chemistry Testing
    • 7.7.4 Therapeutic Drug Monitoring (TDM) Testing
  • 7.8 Biochemistry
  • 7.9 Esoteric Tests
  • 7.10 Food Intolerance Test
  • 7.11 Histopathology & Anatomic Pathology Services
  • 7.12 Urinalysis
  • 7.13 Other Specialties
    • 7.13.1 Hair Testing
    • 7.13.2 Oral Fluid Testing

8 Global Clinical Laboratory Services Market, By Product

  • 8.1 Introduction
  • 8.2 Instruments
  • 8.3 Reagents
  • 8.4 Services

9 Global Clinical Laboratory Services Market, By Ownership

  • 9.1 Introduction
  • 9.2 Private
  • 9.3 Public

10 Global Clinical Laboratory Services Market, By Application

  • 10.1 Introduction
  • 10.2 Toxicology Testing Services (Drug of Abuse Testing)
  • 10.3 Preclinical & Clinical Trial Related Services
  • 10.4 Drug Discovery & Development Related Services
  • 10.5 Cell & Gene Therapy Related Services
  • 10.6 Bioanalytical & Lab Chemistry Services

11 Global Clinical Laboratory Services Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Sonic Healthcare
  • 13.2 Viapath
  • 13.3 Spectra Laboratories
  • 13.4 ACM Global Laboratories
  • 13.5 BioReference Laboratories
  • 13.6 Quest Diagnostics
  • 13.7 Clinical Reference Laboratory
  • 13.8 OPKO Health, Inc.
  • 13.9 NeoGenomics Laboratories
  • 13.10 Eurofins Scientific
  • 13.11 Labcorp
  • 13.12 Fresenius Medical Care
  • 13.13 Myriad Genetics
  • 13.14 Charles River Laboratories
  • 13.15 QIAGEN
  • 13.16 Mindray
  • 13.17 Bio-Rad Laboratories
  • 13.18 Deep Bio
  • 13.19 Siemens Healthineers
  • 13.20 Abbott Laboratories